Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER_GOV × Small Cell Lung Cancer Recurrent × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 57 Stomach Neoplasms 41 Neoplasms 41 Colorectal Neoplasms 38 Carcinoma, Non-Small-Cell Lung 34 Uterine Cervical Neoplasms 27 Lung Neoplasms 26 Carcinoma, Hepatocellular 25 Rectal Neoplasms 24 Prostatic Neoplasms 23 Recurrence 18 Ovarian Neoplasms 16 Colonic Neoplasms 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Neoplasm Metastasis 15 Thyroid Neoplasms 14 Urinary Bladder Neoplasms 13 Nasopharyngeal Carcinoma 13 Pancreatic Neoplasms 12 Esophageal Neoplasms 12 Motor Activity 11 Leukemia, Myeloid, Acute 11 Lymphoma, Non-Hodgkin 10 Lymphoma 10 Head and Neck Neoplasms 10 Small Cell Lung Carcinoma 9 Sarcoma 9 Papillomavirus Infections 9 Multiple Myeloma 9 Squamous Cell Carcinoma of Head and Neck 8

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03262454 2022-04-06

Atezolizumab

National Cancer Center, Korea

Phase 2 Unknown

Small Cell Lung Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡